Glenmark recalls 114 batches of low potassium drug in the US over potentially deadly hyperkalemia risk

While patients with low potassium often need medication to boost levels of the electrolyte in the body, too much of a good thing can cause serious health concerns.

Glenmark Pharmaceuticals on Tuesday said it’s recalling 114 batches of 750mg potassium chloride extended-release capsules thanks to failed dissolution of the product.